Duncker Streett & CO Inc Novavax Inc Transaction History

Duncker Streett & CO Inc

  • $542 Million
  • Q3 2024

A detailed history of Duncker Streett & CO Inc transactions in Novavax Inc stock. As of the latest transaction made, Duncker Streett & CO Inc holds 417 shares of NVAX stock, worth $3,623. This represents 0.0% of its overall portfolio holdings.

Number of Shares
417
Previous 417 -0.0%
Holding current value
$3,623
Previous $5,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 28, 2021
BUY
$112.98 - $319.93 $20,336 - $57,587
180 Added 75.95%
417 $76,000
Q3 2020

Oct 28, 2020
BUY
$79.44 - $178.51 $18,827 - $42,306
237 New
237 $26,000

Others Institutions Holding NVAX

# of Institutions
288
Shares Held
94.7M
Call Options Held
6.95M
Put Options Held
9.4M
View Full List

About NOVAVAX INC

NVAX Quotes by TradingView
  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $680M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Duncker Streett & CO Inc Portfolio

Follow Duncker Streett & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Duncker Streett & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Duncker Streett & CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email